Thursday, January 8, 2026
HomeNews

News

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate LVGN7409

Lyvgen Biopharma, a leading innovative global biotech company dedicated to discovering, developing and commercializing first-in-class and best-in-class biotherapeutics for cancer, announced an open label,...

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC...

Univar Solutions Confirms Preliminary Indication of Interest from Brenntag SE

Univar Solutions Inc., a leading global solutions provider to users of specialty ingredients and chemicals, confirmed that it has received a preliminary indication of...

Unifiller Identifies The Impact of Employee Burnout in Food Production Plants

Burnout is frequently understood as work-related or work-induced stress and fatigue. It is being increasingly discussed in the present-day culture, but it’s not exactly...

Almirall Joins Facilitate, a Patient-Driven IMI Project to Enable the Use of Clinical Trial Data by Study Participants

Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, announced that it is participating in FACILITATE, (FrAmework for ClInicaL trIal participants’ daTA...
0FansLike
0FollowersFollow
spot_img

Hot Topics